IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q1 2018 Holdings

Filed 2018-05-15 | 11 holdings | $5.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adaptimmune Therapeutics PLC(ADAPY)SPONDS ADR00653A107$4.5M400,00080.3%
Ardelyx Inc.(ARDX)COM039697107$808.0K159,96714.4%
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$105.7K3,319,9451.9%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$90.7K1,672,7141.6%
Epizyme, Inc.(EPZMEUR)COM29428V104$27.7K1,558,1080.5%
Insmed Incorporated(INSM)COM457669307$21.8K967,6360.4%
Alder BioPharmaceuticals, Inc.(ALDR1EUR)COM014339105$21.4K1,686,2200.4%
Aimmune Therapeutics, Inc.PutCOM00900T957$13.9K437,9000.2%
Acceleron Pharma Inc.(XLRN)COM00434H108$9.6K244,7560.2%
Denali Therapeutics Inc.(DNLI)COM24823R105$3.7K250,0000.1%
Sangamo Therapeutics, Inc.(SGMO)COM800677106$87746,1380.0%